Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival ...

A research team at Lund University in Sweden has discovered a certain type of cell—foam cells—in patients with the aggressive ...

Researchers have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy. The strategy, which they demonstrated in cells in the lab, forces brain cancer ...

Newly discovered targets may hold the key to effectively treating glioblastoma, a deadly form of brain cancer. These targets ...

Chen recommended a minimally invasive procedure that uses heat to target the remaining tumor cells. This technique, done in ...

Mathew Clement receives funding from the Brain Tumour Charity (Future Leader Fellowship scheme), the Wales Cancer Research Centre and Systems Immunity Research Institute (Cardiff University).

Cardiff: Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis - the average survival after diagnosis is between 12 and 15 months. And just 6.9% of ...

(MENAFN- The Conversation) Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis – the average survival after diagnosis is between 12 and 15 months.

SYNC, its first homegrown CAR-T therapy, one of the first to show promise in treating certain types of brain cancers. This ...

Now there is hope after researchers developed a new imaging technique which can help spot which patients will benefit from ...